Mar 09, 2016 7:00 am EST Heat Biologics’ CSO to Participate in the 27th Annual Cancer Progress Conference by Defined Health
Mar 07, 2016 4:05 pm EST Heat Biologics Presents Positive ComPACT Preclinical Data at the Keystone Symposia
Feb 25, 2016 7:00 am EST Heat Biologics Provides Update on Its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm
Jan 26, 2016 7:00 am EST Heat Biologics CSO to Present Interim Results From the Monotherapy Arm in Its Ongoing HS-410 Phase 2 Bladder Cancer Trial at the Phacilitate Immunotherapy World Conference